Pulmonary Function Tests (PFTs) are key diagnostic tools in respiratory medicine, providing valuable insights into the functional status of the lungs. However, their interpretation can be complex and daunting for healthcare professionals. This article aims to simplify the understanding of PFTs and enhance their practical application.
Spirometry measures the amount (volume) and the speed (flow) of air that can be inhaled and exhaled. Key parameters include Forced Vital Capacity (FVC), Forced Expiratory Volume in the first second (FEV1), and their ratio (FEV1/FVC), which are essential in diagnosing obstructive and restrictive lung diseases.
These tests measure the capacity of the lungs to transfer gas from inhaled air to the red blood cells. The most common is the Diffusing capacity of the Lung for Carbon Monoxide (DLCO). Decreased DLCO may indicate conditions like pulmonary fibrosis or emphysema.
These tests provide information about the size of the lungs and the resistance to airflow in the bronchial tubes. They can be useful in diagnosing conditions like asthma and chronic obstructive pulmonary disease (COPD).
These tests measure lung function during physical activity. They can help identify exercise-induced bronchospasm, unexplained dyspnea, and assess suitability for lung surgery.
Interpreting PFTs is a critical skill for healthcare professionals involved in respiratory care. By understanding the various components of PFTs, clinicians can make accurate diagnoses, monitor disease progression, and guide therapeutic decisions. Continuous education and practice are key to mastering this essential tool in pulmonary medicine.
1.
Research discovery halts childhood brain tumor before it forms
2.
Increased Data Support Active Monitoring for Low-Risk Prostate Cancer.
3.
'CDC Must Be Investigated'; David Lynch, Bob Uecker Die; Nasal Epinephrine Warning
4.
Increasing Access to Prostate Cancer Drugs; Reducing Toxic Emissions; FTC Files a 'Charity' Suit.
5.
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers
1.
Beyond the Blinders: A Review of Targeted Therapeutic Strategies for Triple-Negative Breast Cancer in 2025
2.
AI-Based Cancer Follow-Up Monitoring: Transforming Survivorship Care through Intelligent Surveillance
3.
Preventing Sarcopenia During Cancer Treatment
4.
Guidance for Managing Complex Anticoagulation
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on Standard V/S High Risk Myeloma Treatment
2.
Navigating the Complexities of Ph Negative ALL - Part XIV
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation